Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Retinitis Pigmentosa
Type
Interventional
Phase
Not Applicable
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Screening

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

This is an open, longitudinal, ambispective, single center study to describe one-year disease progression in patients with retinitis pigmentosa due to mutation in genes with selective expression in rods: rhodopsin (RHO), phosphodiesterase 6A (PDE6A) or phosphodiesterase 6B (PDE6B).RHO,PDE6A or PDE6B...

This is an open, longitudinal, ambispective, single center study to describe one-year disease progression in patients with retinitis pigmentosa due to mutation in genes with selective expression in rods: rhodopsin (RHO), phosphodiesterase 6A (PDE6A) or phosphodiesterase 6B (PDE6B).RHO,PDE6A or PDE6B mutation.

Tracking Information

NCT #
NCT04285398
Collaborators
Not Provided
Investigators
Principal Investigator: Saddek Mohand-Saïd, MD, PhD CHNO XV-XX Paris - CIC 1423